Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,229,000 | 5,524,000 | 12,814,000 | 9,201,000 | 9,746,000 |
| Marketable Securities | 28,000 | 31,000 | 2,000 | 28,000 | 84,000 |
| Receivables | 12,589,000 | 10,919,000 | 11,155,000 | 11,254,000 | 9,977,000 |
| Inventories | 4,951,000 | 4,181,000 | 4,099,000 | 3,579,000 | 3,128,000 |
| TOTAL | $29,062,000 | $25,582,000 | $33,002,000 | $28,463,000 | $27,928,000 |
| Non-Current Assets | |||||
| PPE Net | 5,628,000 | 5,134,000 | 4,989,000 | 4,935,000 | 5,110,000 |
| Investments And Advances | 268,000 | 279,000 | 304,000 | 241,000 | 277,000 |
| Intangibles | 88,281,000 | 95,024,000 | 87,903,000 | 99,595,000 | 108,330,000 |
| Other Non-Current Assets | 10,721,000 | 9,142,000 | 8,513,000 | 5,571,000 | 4,884,000 |
| TOTAL | $104,898,000 | $109,579,000 | $101,709,000 | $110,342,000 | $118,601,000 |
| Total Assets | $133,960,000 | $135,161,000 | $134,711,000 | $138,805,000 | $146,529,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,555,000 | 6,804,000 | 7,191,000 | 4,136,000 | 12,495,000 |
| Accounts payable and accrued liabilities | 34,734,000 | 31,945,000 | 30,650,000 | 25,402,000 | 22,699,000 |
| TOTAL | $43,289,000 | $38,749,000 | $37,841,000 | $29,538,000 | $35,194,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 58,941,000 | 60,340,000 | 52,194,000 | 59,135,000 | 64,189,000 |
| Other Non-Current Liabilities | 32,562,000 | 30,121,000 | 32,317,000 | 30,646,000 | 28,694,000 |
| TOTAL | $93,899,000 | $93,048,000 | $86,473,000 | $91,980,000 | $95,899,000 |
| Total Liabilities | $137,188,000 | $131,797,000 | $124,314,000 | $121,518,000 | $131,093,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,768,169 | 1,765,355 | 1,766,473 | 1,769,400 | 1,768,754 |
| Common Shares | 18,000 | 18,000 | 18,000 | 18,000 | 18,000 |
| Retained earnings | -15,493,000 | -7,900,000 | -1,000,000 | 4,784,000 | 3,127,000 |
| Other shareholders' equity | -1,102,000 | -1,886,000 | -2,268,000 | -2,166,000 | -2,871,000 |
| TOTAL | $-3,228,000 | $3,364,000 | $10,397,000 | $17,287,000 | $15,436,000 |
| Total Liabilities And Equity | $133,960,000 | $135,161,000 | $134,711,000 | $138,805,000 | $146,529,000 |